Cova B, de Oliveira L, Lima Machado P, de Carvalho E, Monte-Alegre A, Schriefer A
Parasit Vectors. 2025; 18(1):79.
PMID: 40011928
PMC: 11866633.
DOI: 10.1186/s13071-025-06717-y.
Paes L, Oliveira R, Magalhaes M, Pimentel M, Lyra M, Carvalho-Paes L
PLoS One. 2024; 19(12):e0308298.
PMID: 39739918
PMC: 11687719.
DOI: 10.1371/journal.pone.0308298.
Pinheiro A, Torrecilhas A, Souza B, Cruz F, de Matos Guedes H, Ramos T
J Extracell Vesicles. 2024; 13(8):e12496.
PMID: 39113589
PMC: 11306921.
DOI: 10.1002/jev2.12496.
Albuquerque-Melo B, Pereira B, Ennes-Vidal V, Goncalves M, Cortes L, Cysne-Finkelstein L
Mem Inst Oswaldo Cruz. 2024; 119:e240038.
PMID: 38985089
PMC: 11251415.
DOI: 10.1590/0074-02760240038.
Abreu C, Nascimento M, Bacellar O, Carvalho L, Carvalho E, Cardoso T
Pathogens. 2024; 13(6).
PMID: 38921758
PMC: 11207099.
DOI: 10.3390/pathogens13060460.
Contrasting Phenotypes of Neutrophils During Asymptomatic Versus Symptomatic Leishmania braziliensis Infection.
Conceicao J, Carneiro P, Dorea A, Oliveira W, Muniz A, Carvalho E
J Infect Dis. 2024; 230(6):e1385-e1393.
PMID: 38912968
PMC: 11646601.
DOI: 10.1093/infdis/jiae317.
Pentavalent Antimony Associated with G-CSF in the Treatment of Cutaneous Leishmaniasis Caused by .
Suprien C, Guimaraes L, de Carvalho L, Machado P
Pathogens. 2024; 13(4).
PMID: 38668256
PMC: 11054058.
DOI: 10.3390/pathogens13040301.
Disseminated Leishmaniasis, a Severe Form of Leishmania braziliensis Infection.
Machado P, Lago A, Cardoso T, Magalhaes A, Carvalho L, Lago T
Emerg Infect Dis. 2024; 30(3):510-518.
PMID: 38407142
PMC: 10902519.
DOI: 10.3201/eid3003.230786.
Prostaglandin E2 contributes to survival and therapeutic failure in cutaneous leishmaniasis.
Nascimento M, Viana D, Peixoto F, Arruda S, Carvalho E, Carvalho L
Emerg Microbes Infect. 2023; 12(2):2261565.
PMID: 37729084
PMC: 10540647.
DOI: 10.1080/22221751.2023.2261565.
Dogs Harbor and Participate in the Transmission Cycle of Human Tegumentary Leishmaniasis.
Lago J, Fraga D, Coelho L, Jesus M, Leite B, Werneck G
Pathogens. 2023; 12(8).
PMID: 37623941
PMC: 10458093.
DOI: 10.3390/pathogens12080981.
Clinical Profile and Diagnosis of Recurrent Cutaneous Leishmaniasis.
Arruda S, Agra-Duarte G, Lago J, Oliveira L, Zacarias E, Carvalho L
Open Forum Infect Dis. 2023; 10(8):ofad387.
PMID: 37564745
PMC: 10411034.
DOI: 10.1093/ofid/ofad387.
Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study.
Castro M, Rode J, Machado P, Llanos-Cuentas A, Hueb M, Cota G
PLoS Negl Trop Dis. 2023; 17(1):e0011029.
PMID: 36689465
PMC: 9894540.
DOI: 10.1371/journal.pntd.0011029.
Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a -endemic area.
Barroso D, Goncalves R, Barbosa J, da Motta J, Freire G, Gomes C
Front Cell Infect Microbiol. 2022; 12:993338.
PMID: 36211958
PMC: 9538529.
DOI: 10.3389/fcimb.2022.993338.
Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins.
Viana S, Montoya A, Carvalho A, de Mendonca B, Portillo S, Olivas J
Emerg Microbes Infect. 2022; 11(1):2147-2159.
PMID: 36039908
PMC: 9518598.
DOI: 10.1080/22221751.2022.2114852.
Ageing impairs protective immunity and promotes susceptibility to murine visceral leishmaniasis.
Salgado C, Corea A, Polaco Covre L, De Matos Guedes H, Falqueto A, Gomes D
Parasitology. 2022; 149(9):1249-1256.
PMID: 35670372
PMC: 11010576.
DOI: 10.1017/S0031182022000828.
Immune Response to LinB13, a Lutzomyia Intermedia Salivary Protein Correlates With Disease Severity in Tegumentary Leishmaniasis.
Carvalho A, Viana S, Andrade B, Oliveira F, Valenzuela J, Carvalho E
Clin Infect Dis. 2022; 75(10):1754-1762.
PMID: 35385578
PMC: 9662176.
DOI: 10.1093/cid/ciac258.
Nitric Oxide Resistance in () Involves Regulation of Glucose Consumption, Glutathione Metabolism and Abundance of Pentose Phosphate Pathway Enzymes.
Pinho N, Bombaca A, Wisniewski J, Dias-Lopes G, Saboia-Vahia L, Cupolillo E
Antioxidants (Basel). 2022; 11(2).
PMID: 35204161
PMC: 8868067.
DOI: 10.3390/antiox11020277.
Influence of Intestinal Helminth Burden on Clinical Manifestations, Therapeutic Response, and Leishmania braziliensis Load in Patients with New World Cutaneous Leishmaniasis.
Page B, Lago A, Silva J, Schriefer A, Lago J, Oliveira L
Am J Trop Med Hyg. 2021; 105(4):1060-1066.
PMID: 34398812
PMC: 8592135.
DOI: 10.4269/ajtmh.20-1664.
A Cytokine Network Balance Influences the Fate of Infection in a Cutaneous Leishmaniasis Hamster Model.
Paiva M, Ribeiro-Romao R, Resende-Vieira L, Braga-Gomes T, Oliveira M, Saavedra A
Front Immunol. 2021; 12:656919.
PMID: 34276650
PMC: 8281932.
DOI: 10.3389/fimmu.2021.656919.
Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL).
Volpedo G, Pacheco-Fernandez T, Holcomb E, Cipriano N, Cox B, Satoskar A
Front Cell Infect Microbiol. 2021; 11:685296.
PMID: 34169006
PMC: 8217655.
DOI: 10.3389/fcimb.2021.685296.